Totality of Evidence Including PBPK Modeling to Support BE Assessment and Approval of Mesalamine Delayed Release Tablets (Part II)

Author/sWu, Fang

Date:09/25/2024

Meeting Name:Small Business and Industry Assistance (SBIA) Workshop: Advancing Generic Drug Development: Translating Science to Approval 2024

State:MD

City:Bethesda